Baxter Launches Peri-Strips Dry With Secure Grip Technology for Reliable Staple Line Reinforcement in Surgical Procedures
Baxter International Inc. (BAX)
Last baxter international inc. earnings: 4/30 07:15 am
Check Earnings Report
US:NYSE Investor Relations:
investor.baxter.com
Company Research
Source: Business Wire
Staple line reinforcement helps mitigate bleeding during bariatric and other proceduresStaple line bleeding can cause significant complications for patientsNew format of Peri-Strips Dry is made from same biologic material but is two times faster to prepare than the previous version DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, announced 510(k) clearance from the U.S. Food and Drug Administration for a new generation of its Peri-Strips Dry with Veritas Collagen Matrix (PSDV) product, known as PSDV with Secure Grip. Now available with “peel and secure” technology, PSDV is a staple line reinforcement material that bariatric surgeons have used to mitigate staple line complications for more than 15 years. This new generation of PSDV is two times faster to prepare compared to the previous version and another staple line reinforcement product.1This press release features multimedia. View the full release here: htt
Show less
Read more
Impact Snapshot
Event Time:
BAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAX alerts
High impacting Baxter International Inc. news events
Weekly update
A roundup of the hottest topics
BAX
News
- Peritoneal Dialysis Market Research 2024-2034: Growing Prevalence of Chronic Diseases Underscores Need for Dialysis Innovations [Yahoo! Finance]Yahoo! Finance
- Baxter to Present at 43rd Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- The Global Market for Motion Sickness Treatment, 2024-2030: Increasing Preference for OTC Solutions Strengthens Business Case [Yahoo! Finance]Yahoo! Finance
- Moon Surgical Appoints Chris Toth as Independent Board Member Ahead of Commercial Acceleration [Yahoo! Finance]Yahoo! Finance
- Baxter International Inc. (NYSE: BAX) had its price target lowered by analysts at Citigroup Inc. from $37.00 to $35.00. They now have a "neutral" rating on the stock.MarketBeat
BAX
Earnings
- 11/8/24 - Miss
BAX
Sec Filings
- 12/17/24 - Form 4
- 12/4/24 - Form 4
- 12/4/24 - Form 4
- BAX's page on the SEC website